Announcement on Obtaining Drug Registration Certificate for Etoposide Injecton
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Obtaining Drug Registration Certificate for Etoposide Injecton
Filed with SSE · · 2 pages · Chinese
Release
Sichuan Huiyu Pharmaceutical Co. Ltd. on 6ix
Earlier from Sichuan Huiyu Pharmaceutical
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Participation of the Company and Its Related Parties in Private Equity Fund Investment and Related Party Transaction
- Announcement on Voluntary Disclosure of Prospective Winning in the National Centralized Drug Procurement
- Announcement on Judicial and Rotary Freezing of Shares Held by Shareholder with Over 5% Shares
- Announcement on Progress in Providing Guarantees for Wholly-owned Subsidiary
Later from Sichuan Huiyu Pharmaceutical
- Announcement on Voluntary Disclosure of the Acceptance of IND Application for the Drug Combination Involving HYP-6589 Tablets
- Announcement on Cooperation with Professional Institutions to Invest in the Establishment of a Private Equity Fund
- Announcement on Obtaining Drug Registration Certificate for Nicardipine Hydrochloride Injection
- Announcement on Progress in Participation in Private Equity Fund Investment and Related Party Transaction
- Announcement on Obtaining Drug Registration Certificate for Cimetidine Injection
Follow Sichuan Huiyu Pharmaceutical into a list and get an email when it puts out news.
Follow Sichuan Huiyu Pharmaceutical